Discontinued — last reported Q4 '20
Over 3 years (FY 2021 to FY 2024), Business Sale Proceeds shows a downward trend with a -57.3% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.50M | $800.00K | $300.00K | $9.70M | $55.30M | $4.00M | $0.00 | $4.60M | $25.80M | $0.00 | $2.40M | $425.00K | $425.00K | $425.00K | $425.00K | $0.00 | $21.70M |
| QoQ Change | — | -91.6% | -62.5% | >999% | +470.1% | -92.8% | -100.0% | — | +460.9% | -100.0% | — | -82.3% | +0.0% | +0.0% | +0.0% | -100.0% | — |
| YoY Change | — | — | — | — | +482.1% | +400.0% | -100.0% | -52.6% | -53.3% | -100.0% | — | -90.8% | -98.4% | — | -82.3% | -100.0% | — |